Exceptional Clinical Trial Volunteers Presented National Citizen Scientist Awards for Research Efforts

Key Takeaways:

• The Global Alzheimer’s Platform Foundation (GAP) announced the 2025 National Citizen Scientist Award honorees.
• Volunteers are crucial to clinical trials, yet up to 90% of studies are delayed by a shortage of participants.
• Honorees include individuals living with dementia, a yoga teacher, a patient-led organization, and community groups.
• GAP supports over 100 research sites worldwide, fostering collaboration in Alzheimer’s and Parkinson’s research.
• More than 119 volunteers were nominated this year, reflecting a growing commitment to clinical research participation.

A Major Moment for Volunteer Recognition

The Global Alzheimer’s Platform Foundation (GAP) recently announced the honorees for its 2025 National Citizen Scientist Awards, celebrating the extraordinary individuals who lend their time and energy to advance clinical trials for neurodegenerative diseases. Their stories highlight a shared purpose: to expedite life-changing treatments for conditions like Alzheimer’s and Parkinson’s disease.

Diverse Honorees Leading the Way

This year’s recipients are a varied group—a woman living with early-onset Alzheimer’s disease who launched a YouTube series to spread awareness, a former researcher bravely documenting his journey with Lewy Body Dementia, a leader of a patient-led organization for families affected by early onset familial Alzheimer’s, a devoted yoga teacher turned research advocate, an innovative seniors program prioritizing brain health education, and a faith-based community integrating brain health into its congregation. GAP-Net research sites nominated more than 119 deserving volunteers for these accolades.

Why Volunteers Matter So Much

Securing and retaining enough clinical trial participants remains one of the greatest hurdles in bringing new therapies to those dealing with Alzheimer’s and Parkinson’s. Upwards of 90% of these trials are delayed due to insufficient volunteer enrollment. Each honoree’s involvement underscores how crucial everyday citizens are to the pursuit of medical breakthroughs.

GAP’s Expanding Global Network

With over 100 research sites in North America and around the world, GAP and its GAP-Net ecosystem collaborate to streamline clinical trials and accelerate discoveries. These sites champion the volunteers’ hard work, recognizing that every participant contributes to a healthier future.

Gratitude from Foundation Leadership

“We are deeply thankful to our study participants and community partners whose invaluable contributions are advancing CNS science and accelerating the development of therapies and cures for neurodegenerative diseases,” said John Dwyer, President of the Global Alzheimer’s Platform Foundation. He particularly thanked “Ann, Jim, Scott, Brian, Deborah of the Wayne Densch YMCA, and the Hyde Park United Methodist Church,” emphasizing that their work is immeasurable in improving the lives of people in their communities.

Looking Toward Continued Progress

The 2025 Citizen Scientist Award honorees illustrate the numerous ways individuals can drive forward research in the fight against neurodegenerative conditions. As more volunteers join clinical trials, the chances for new therapies and scientific breakthroughs steadily grow—bringing renewed hope to millions facing Alzheimer’s and Parkinson’s worldwide.